Glucose Regulates the Transcription of Human Genes Relevant to HDL Metabolism: Responsive Elements for Peroxisome Proliferator-Activated Receptor Are Involved in the Regulation of Phospholipid Transfer Protein

Diabetes

Volumn 50, Issue 8, 2001, Pages 1851-1856

  Tu, An Yue ^a   Albers, John J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CARRIER PROTEIN; CELL RECEPTOR; DNA BINDING PROTEIN; FARNESOID X RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOLIPID TRANSFER PROTEIN; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR B; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL LIPASE;

ARTICLE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LIPASE; LIPOPROTEINS, HDL; LIVER NEOPLASMS; MEMBRANE PROTEINS; PHOSPHOLIPID TRANSFER PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035432293     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1851     Document Type: Article

References (51)

1. Miller GJ, Miller NE: Plasma high-density lipoprotein concentration and development of ischaemic heart disease. Lancet 1:16-19, 1975
2. Cheung MC, Brown B, Wolf AC, Albers JJ: Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32:38:3-394, 1991
3. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211-228, 1995
4. Tall AR, Jiang X-C, Luo Y, Silver D: Lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol 20:1185-1188, 2000
5. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF: The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104: R25-R31, 1999
6. Ji Y, Wang N, Ramakrishnan R, Sehayek E, Huszar D, Breslow JL, Tall AR: Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 274:33398-33402, 1999
7. Tu A-Y, Nishida HI, Nishida T: High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 268:23098-23105, 1993
8. Albers JJ, Wolfbauer G, Cheung MC, Day JR, Ching AFT, Lok S, Tu A-Y: Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim Biophys Acta 1258:27-34, 1995
9. Von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, Wu S, Ehnholm C, Assmann G: Phospholipid transfer protein mediated conversion of high density lipoproteins generates prebeta-HDL. Biochim Biophys Acta 1301:255-262, 1996
10. Tu A-Y, Paigen B, Wolfbauer G, Cheung MC, Kennedy H, Chen H, Albers JJ: Introduction of the human PLTP transgene suppresses the atherogenic diet-induced increase in plasma phospholipid transfer activity in C57BL/6 mice. Int. J Clin Lab Res 29:14-21, 1999
11. Jiang X-C, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR: Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 103:907-914, 1999
12. van Haperen R, van Tol A, Vermeulen P, Jauhiainen M, van Gen T, van der Berg P, Ehnholm S, Grosveld F, van der Kamp A, de Crom R: Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 20:1082-1088, 2000
13. Wolfbauer G, Albers JJ, Oram JF: Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta 1439:65-76, 1999
14. Desrumaux C, Athias A, Bessede G, Verges B, Farnier M, Persegol L, Gambert P, Lagrost L: Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 19:266-275, 1999
15. van Tol A, Ligtenberg JJM, Riemens SC, van Haeften TW, Reitsma WD, Dullaart RPF: Lowering of plasma phospholipid transfer protein activity by acute hyperglycemia-induced hyperinsulinaemia in healthy men. Scand J Clin Lab Invest 57:147-158, 1997
16. Riemens SC, van ToI A, Sluiter WJ, Dullaart RPF: Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes 48:1631-1637, 1999
17. Riemens SC, van Tol A, Sluiter WJ, Dullaat RPF: Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese type II diabetic patients. Diabetologia 41:929-934,1998
18. Tan KC, Shiu SW, Chu BY: Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 145:273-278, 1999
19. Syvanne M, Ahola M, Lahdenpera S, Kahri J, Kuusi T, Virtanen KS, Taskinen MR: High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 36:573-582, 1995
20. Romana G, Innelli F, Di Marino L, Annuzzi L, lavicoli M, Coronel GA, Riccardi G, Rivellese AA: Insulin and sulfonylurea therapy in NIDDM patients: are the effects on lipoprotein metabolism different even with similar blood glucose control? Diabetes 46:1601-1606, 1997
21. Tu A-Y, Wolfbauer G, Chen H, Albers JJ: DNA sequences essential for transcription of human phospholipid transfer protein gene in HepG2 cells. Biochem Biophys Res Commun 232:574-577, 1997
22. Tu A-Y, Albers JJ: DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by flbrate. Biochem Biophys Res Commun 264:802-807, 1999
23. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, Edwards PA: Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 275:10638-10647, 2000
24. Urizar NL, Dowhan DH, Moore DD: The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem 275:39313-39317, 2000
25. Langmann T, Klucken J, Reil M, Liebisch G, Luciani M, Chimini G, Kaminski WE, Schmitz G: Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 267:29-33, 1999
26. Calvo D, Vega MA: Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 268:18929-18935, 1993
27. Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, Fielding F, Lawn R: Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327:632-634, 1987
28. Stahnke G, Sprengel R, Augustin J, Will H: Human hepatic triglyceride lipase: cDNA cloning, amino acid sequence and expression in a cultured cell line. Differentiation 35:45-52, 1987
29. Warden CH, Langner CA, Gordon JI, Taylor BA, McLean JW, Lusis AJ: Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: cholesterol acyltransferase gene. J Biol Chem 264:21573-21581, 1989
30. Breslow JL, Ross D, McPherson J, Williams H, Kurnit D, Nussbaum AL, Karathanasis SK, Zannis VI: Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci U S A 79:6861-6865, 1982
31. Knott TJ, Priestley LM, Urdea M, Scott J: Isolation and characterization of a cDNA encoding the precursor for human apolipoprotein All. Biochem Biophys Res Commun 120:734-740, 1984
32. Tu A-Y, Deeb SS, Iwasaki L, Day JR, Albers JJ: Organization of human phospholipid transfer protein gene. Biochem Biophys Res Commun 207: 552-558, 1995
33. Costet P, Luo Y, Wang N, Tall AR: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275:28240-28245, 2000
34. Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH: Structure and localization of the human gene encoding SR-BI/CLA-1. J Biol Chem 272:33068-33076, 1997
35. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, Schotz MC, Will H: Isolation and characterization of the human hepatic lipase gene. J Biol Chem 265:6552-6555, 1990
36. Higuchi K, Law SW, Hoeg JM, Schumacher UK, Meglin N, Brewer HB Jr: Tissue-specific expression of apolipoprotein A-I (apo A-I) is regulated by the 5′-flanking region of the human apo A-I gene. J Biol Chem 263:18530-18536, 1988
37. Sartippour MR, Renier G: Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose: role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. Arterioscler Thromb Vasc Biol 20:104-110, 2000
38. Roduit R, Morin J, Masse F, Segall L, Roche E, Newgard CB, Assimacopoulos-Jeannet F, Prentki M: Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta-cell. J Biol Chem 275:35799-35806, 2000
39. Quintao ECR, Medina WL, Passarelli M: Reverse cholesterol transport in diabetes mellitus. Diabetes Metab Res Rev 16:237-250, 2000
40. Tu A-Y, Wolfbauer G, Albers JJ: Functional characterization of the promoter region of the human phospholipid transfer protein gene. Biochem Biophys Res Commun 217:705-711, 1995
41. Schoonjans K, Martin G, Staels B, Auwerx J: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166, 1997
42. Torra IP, Gervois P, Staels B: Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol 10:151-159, 1999
43. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: the second decade. Cell 83:835-839, 1995
44. Luo Y, Tall AR: Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest. 105:513-520, 2000
45. Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antomicci M, Poulain P, Chapman J, Fruchart JC, Tedgui A, Najib-Fruchart J, Staels B: CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101:2411-2417, 2000
46. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart J-C, Clavey V, Staels B: PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53-58, 2001
47. Staels B, Auwerx J: Regulation of apo A-I gene expression by fibrates. Atherosclerosis 137:S19-S23, 1998
48. Chen Y-Q, Su M, Walia RR, Hao Q, Covington JW, Vaughan DE: Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 273:8225-8231, 1998
49. Murao K, Wada Y, Nakamura T, Taylor AH, Mooradian AD, Wong NCW: Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J Biol Chem 273:18959-18965, 1998
50. Shimomura I, Bashmakov Y, Horton JD: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032, 1999
51. Hasty AH, Shimano H, Yahagi N, Amemiya-Kudo M, Perrey S, Yoshikawa T, Osuga J, Okazaki H, Tamura Y, Iizuka Y, Shionoiri F, Ohashi K, Harada K, Gotoda T, Nagai R, Ishibashi S, Yamada N: Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level. J Biol Chem 275:31069-31077, 2000